Immunovant anticipates initiating clinical trials evaluating IMVT-1402 in a total of ten indications by March 31, 2026. Neurology Program: ...

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

THE family of a "beloved father and husband" who took his own life after Covid-19 vaccine complications are fighting for justice.

Patients with COVID-19 who developed chronic inflammatory demyelinating polyneuropathy (CIDP) as a complication could follow a specific pattern in medical management, according to a study published in ...

But doctors are rushed in appointments, and having to make a diagnosis and come up with a treatment plan already takes up more time than is allotted for most appointments. And with a disease like CIDP ...

Myelin is an insulating layer of lipids and proteins surrounding nerves. Myelin damage can cause problems with the nerves’ ability to send and receive electrical messages. Inflammatory disorders ...

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment ...

We recently published a list of 12 High Growth International Stocks to Invest in Now. In this article, we are going to take a look at where Ascendis Pharma A/S (NASDAQ:ASND) stands against other high ...

Among 2024’s notable new drugs were three approvals for antibiotic therapies: Allecra Therapeutics’ Exblifep (cefepime and enmetazobactam), Basilea Pharmaceutica’s Zevtera (ceftobiprole ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...